An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Exclusion Criteria

• •Prior cancer vaccine therapy or concurrent participation in any other investigational study
• •A history of HIV, Hepatitis B or C, or any other acute medical condition which may compromise patient safety or the activity of the study vaccine treatment
• •A history of adverse reactions following administration of any vaccines, or a history of hypersensitivity to any components of the study vaccine
• •Women who are pregnant, intend to become pregnant, or who are breast feeding